# Modex Therapeutics, Inc.

Canonical: https://abierto.us/vendors/modex-therapeutics-inc-cdvmnsmrdtw8

- UEI: CDVMNSMRDTW8
- CAGE: 8TB78
- Location: Natick, MA
- Awards in window: 1 (5 transactions), $44,517,008 obligated, September 11, 2024 to December 23, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $44,517,008

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $44,517,008

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00056 (definitive contract): $44,517,008, Barda - Aspr / Daappo / Barda DCMA. Advance the Development of Potent, Cross-Reactive Multispecific Antibodies for the Prep Countermeasure of Covid-19 and Seasonal and Highly Pathogenic Avian Influenza.. https://www.usaspending.gov/award/CONT_AWD_75A50123C00056_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/modex-therapeutics-inc-cdvmnsmrdtw8.